enow.com Web Search

  1. Ads

    related to: probiotic strain selection guidelines for cancer patients

Search results

  1. Results from the WOW.Com Content Network
  2. Escherichia coli NC101 - Wikipedia

    en.wikipedia.org/wiki/Escherichia_coli_NC101

    Escherichia coli (AIEC) NC101 is a mouse isolate, serotype O2:H6/41, that is pro-carcinogenic, adherent-invasive (AIEC), probiotic strain of Escherichia coli, a species of bacteria that thrives in the intestines of mammals.

  3. Probiotic - Wikipedia

    en.wikipedia.org/wiki/Probiotic

    The potential efficacy of probiotics to treat AAD depends on the probiotic strains and dosage. [ 100 ] [ 101 ] One review recommended for children L. rhamnosus or Saccharomyces boulardii at 5 to 40 billion colony-forming units/day, given the modest number needed to treat and the likelihood that adverse events are very rare. [ 94 ]

  4. Lactobacillus delbrueckii subsp. bulgaricus - Wikipedia

    en.wikipedia.org/wiki/Lactobacillus_delbrueckii...

    According to Helen Nauts from Cancer Research Institute, on a monograph reviewing the effects of bacterial infections on multiple types of cancer, Ivan Bogdanov, a Bulgarian physician, allegedly produced a vaccine consisting of lactobacillus bulgaricus and used it to treat two patients with myeloma, inducing remission in the two cases, one ...

  5. Saccharomyces boulardii - Wikipedia

    en.wikipedia.org/wiki/Saccharomyces_boulardii

    Saccharomyces boulardii is a tropical yeast first isolated from lychee and mangosteen peels in 1923 by French scientist Henri Boulard.Although early reports claimed distinct taxonomic, metabolic, and genetic properties, [1] S. boulardii is a grouping of S. cerevisiae strains, all sharing a >99% genomic relatedness.

  6. Lacticaseibacillus casei - Wikipedia

    en.wikipedia.org/wiki/Lacticaseibacillus_casei

    L. casei has been combined with other probiotic strains of bacteria in randomized trials studying its effects in preventing antibiotic-associated diarrhea (AAD) and Clostridioides difficile infections (CDI), and patients in the trials who were not given the placebo had significantly lower rates of AAD or CDI (depending on the trial) with no ...

  7. Lacticaseibacillus rhamnosus - Wikipedia

    en.wikipedia.org/wiki/Lacticaseibacillus_rhamnosus

    Lacticaseibacillus rhamnosus GG (ATCC 53103) is a strain of L. rhamnosus that was isolated in 1983 from the intestinal tract of a healthy human being; filed for a patent on 17 April 1985, by Sherwood Gorbach and Barry Goldin, [11] the 'GG' derives from the first letters of their surnames. [12]

  1. Ads

    related to: probiotic strain selection guidelines for cancer patients